FAQ

GIMEMA ALL 0394

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2005-2016
01220052016

Related topics

Related topics

4 relations

Broader (4)

Antineoplastic Combined Chemotherapy ProtocolsCytarabineEtoposideIdarubicin

Related mentions per year

Related mentions per year

1939-2018
19401960198020002020
GIMEMA ALL 0394
Etoposide
Cytarabine
Idarubicin
Antineoplastic Combined Chemotherapy Protocols

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
The NLR and LMR ratio in newly diagnosed MM patients treated upfront with novel agents
Multiple myeloma (MM) is the second most frequent hematological neoplasia, characterized by the accumulation of malignant plasma… (More)
  • figure 1
  • table 1
Is this relevant?
Review
2016
Review
2016
Italian daily platelet transfusion practice for haematological patients undergoing high dose chemotherapy with or without stem cell transplantation: a survey by the GIMEMA Haemostasis and Thrombosis…
BACKGROUND Following high-dose chemotherapy/bone marrow transplantation, patients are routinely, prophylactically transfused with… (More)
Is this relevant?
2014
2014
Bortezomib cumulative dose, efficacy, and tolerability with three different bortezomib-melphalan-prednisone regimens in previously untreated myeloma patients ineligible for high-dose therapy.
Substantial efficacy has been demonstrated with bortezomib-melphalan-prednisone in phase III studies in transplant-ineligible… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
2014
2014
Chromosome 1 abnormalities in elderly patients with newly diagnosed multiple myeloma treated with novel therapies.
Multiple myeloma is a plasma cell disorder characterized by malignant plasma cell infiltration in the bone marrow, serum and/or… (More)
  • table 1
  • table 2
  • figure 1
  • table 3
Is this relevant?
2014
2014
Chromosome 1 abnormalities in newly diagnosed elderly multiple myeloma patients treated with novel therapies RUNNING HEAD : Chr 1 abnormalities in MM treated with new drugs
Multiple Myeloma is a plasma cell disorder, characterized by malignant plasma cell infiltration in the bone marrow, serum and/or… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
Is this relevant?
2013
2013
Absolute monocyte count at diagnosis and survival in mantle cell lymphoma.
Chaperot, L., Bendriss, N., Manches, O., Gressin, R., Maynadie, M., Trimoreau, F., Orfeuvre, H., Corront, B., Feuillard, J… (More)
  • table I
  • figure 1
Is this relevant?
2009
2009
Expression of different isoforms of the B-cell mutator activation-induced cytidine deaminase (AID) in BCR-ABL1-positive acute lymphoblastic leukemia (ALL) patients.
7049 Since the activation-induced cytidine deaminase (AID) enzyme can target non-immunoglobulin (Ig) genes and may even act as a… (More)
Is this relevant?
2006
2006
Adult T-cell acute lymphoblastic leukemia: biologic profile at presentation and correlation with response to induction treatment in patients enrolled in the GIMEMA LAL 0496 protocol.
Between 1996 and 2000, 90 newly diagnosed adult patients with T-acute lymphoblastic leukemia (T-ALL) were registered in the… (More)
  • figure 1
  • table 3
  • table 1
  • table 2
Is this relevant?
2005
2005
GIMEMA-AIEOPAIDA protocol for the treatment of newly diagnosed acute promyelocytic leukemia (APL) in children.
The role of all-trans retinoic acid (ATRA) in pediatric acute promyelocytic leukemia (APL) is the topic of several ongoing… (More)
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2005
2005
Fabrizio the GIMEMA LAL 0496 protocol and correlation with response to induction treatment in patients enrolled in Adult T-cell acute lymphoblastic leukemia : biologic profile at presentation
Prepublished online September 22, 2005; Patrizio Mazza, Claudio Fozza, Francesca Paoloni, Marco Vignetti and Robin Foa' Recchia… (More)
  • figure 1
  • table I
  • table II
  • table III
Is this relevant?